Evidence map›Paper›PMID 33362762›Full record

ArticleFrontiers in immunology2020

TLR4 Response to LPS Is Reinforced by Urokinase Receptor.

Yulia Kiyan, Sergey Tkachuk, Song Rong, Anna Gorrasi, Pia Ragno, Inna Dumler, Hermann Haller, Nelli Shushakova

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Research progress of stem cells in the treatment of atherosclerosis.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yulia KiyanNephrology Department, Hannover Medical School, Hannover, Germany.
Sergey TkachukNephrology Department, Hannover Medical School, Hannover, Germany.
Song RongPhenos GmbH, Hannover, Germany.
Anna GorrasiNouscom, Rome, Italy.
Pia RagnoDepartment of Chemistry and Biology, University of Salerno, Salerno, Italy.
Inna DumlerNephrology Department, Hannover Medical School, Hannover, Germany.
Hermann HallerNephrology Department, Hannover Medical School, Hannover, Germany.
Nelli ShushakovaNephrology Department, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DENouscom (Italy) · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GPI-anchored uPAR is the receptor for the extracellular serine protease urokinase-type plasminogen activator (uPA). Though uPAR role in inflammatory processes is documented, underlying mechanisms are not fully understood. In this study we demonstrate that uPAR is a part of Toll-like receptor 4 (TLR4) interactome. Downregulation of uPAR expression resulted in diminished LPS-induced TLR4 signaling, less activation of NFκB, and decreased secretion of inflammatory mediators in myeloid and non-myeloid cells

Indexed as

AnimalsCD36 AntigensCytokinesDisease Models, AnimalEpithelial CellsHumansInflammationInflammation MediatorsLipopolysaccharidesMacrophages, PeritonealMiceMice, Inbred C57BLMice, KnockoutNF-kappa BRAW 264.7 CellsReceptors, Urokinase Plasminogen ActivatorCD36 AntigensCd36 protein, mouseCytokinesInflammation MediatorsLipopolysaccharidesNF-kappa BPLAUR protein, humanPlaur protein, mouseReceptors, Urokinase Plasminogen ActivatorTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4CD36LPSsepsisTLR4urokinase receptor

Identifiers

PMID33362762
PMCPMC7757075
OpenAlexW3110790698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.